Marco's Morning Report — Saturday, July 11, 2026

Section A — Top Stories confirmed fresh

Mets lose Vientos to a fractured hand — and tip further into sell mode

Mark Vientos took a 92-mph Wacha sinker off the right hand Thursday, fractured it, and landed on the 10-day IL Friday. No surgery, but he's looking at roughly six to eight weeks out. With the club sitting well under .500 and playoff odds fading, insiders now peg the Mets as aggressive sellers into the Aug. 3 deadline — Freddy Peralta looks like a near-lock to be moved, with a handful of relievers likely to follow.

Why it matters to you: your team is officially in retool-and-flip posture. The Vientos injury removes any temptation to buy at the margins; the next three weeks are about who they get back for Peralta.

Talking point: watch the Peralta return — a strong prospect haul would reframe the whole second half. That's the storyline to follow, not the box scores.

Section B — The Debate

Should Medicare use AI to run prior authorization in traditional Medicare?

Why it's live right now: the House Appropriations Committee moved to strip funding from CMS's WISeR pilot — the "Wasteful and Inappropriate Services Reduction" model that started testing AI-assisted prior authorization in six states (including Texas) in January. A bipartisan block of lawmakers, plus a Congressional Review Act push in the Senate, is trying to kill it outright.

For — keep the model

Traditional Medicare pays for a lot of low-value, sometimes harmful care, and CMS has few tools to catch it before the bill lands. Backers at the agency argue WISeR targets a defined list of over-used services, keeps a licensed clinician as the final decision-maker on any denial, and simply brings Original Medicare closer to the review Medicare Advantage already does — with the promise of faster, more consistent calls. The speed-and-consistency case frames the algorithm as triage, not gatekeeping.

Against — kill it

Reps. Greg Landsman and Bonnie Watson Coleman, whose Ban AI Denials in Medicare Act would end WISeR, argue you can't bolt AI-driven denials onto Original Medicare without recreating exactly the delays and administrative burden that make Medicare Advantage maddening. Physician-legislators Ami Bera and Kim Schrier warn the denials "delay patient access to care," and Sen. Ron Wyden's Congressional Review Act resolution questions whether "meaningful human review" is real when a clinician is rubber-stamping an algorithm's call.

Where it might land: the funding block rides on the FY2027 HHS spending bill — so the model's near-term survival is now tangled up in the appropriations fight, not a standalone vote.

Section C — On My Radar

Mets bullpen depth watch: Clay Holmes threw a clean 40-pitch simulated session Thursday (rehabbing the fractured right fibula) — a real step toward a return, and relevant given how thin the pen could get after a Peralta trade. (MLB)

Puerto Rico drought deepening: as of July 7, about 61% of the island is under some level of drought — roughly 51% moderate, 10% severe — heading into the peak-heat weeks. Worth a glance if family or patients have ties there. (SJ Daily Star)

PR fiscal signal: the Oversight Board's FY2027 budget projects tax collections declining year-over-year, though the $63.1M agricultural-incentive package is being held intact. (FOMB)

Clinical beats: no new hospitalist / internal-medicine / family-medicine guideline developments in the last 48 hours. This week's big items (2026 Surviving Sepsis, the bepirovirsen HBV cure data, the risk-guided antihypertensive eligibility piece) are already in your background stack below.

Section D — Trends to Watch

AI as the new prior-auth battleground. WISeR is the federal flashpoint, but the broader signal is states passing their own laws on AI in coverage decisions this year. Where you admit and discharge elderly patients, "who — or what — approved this?" is becoming a live documentation question. Expect utilization-review workflows to keep shifting under you.

Cuba's grid as a chronic, not acute, story. July 6 was the island's third nationwide blackout in six months (grid restored by the 8th). The pattern — dwindling fuel, an aging system — is now structural rather than episodic, with real spillover for anyone tracking Caribbean stability and diaspora health.

Section E — Ideas & Opportunities

Queue for a post-shift wind-down: Man on the Run, the well-reviewed Paul McCartney documentary on his post-Beatles reinvention, is drawing strong critic notices — low-key, no plot to track, good coffee-and-couch fare. (RT)

Golf, if the itch returns: the sub-$250 launch-monitor tier is genuinely usable now — the Shot Scope LM1 (~$200) keeps getting singled out as the honest budget pick if you just want ball-speed and carry numbers on the range without a $2K commitment. (XS Golf)

Section H — Background / Already Covered

Recently reported — no material change (tap to expand)

Cuba nationwide blackout (July 6): third of the year; grid restored July 8. No new development since — moved here to avoid repeating.
2026 Surviving Sepsis Campaign guidelines: 129 statements, greater stewardship emphasis (defer antibiotics in low-risk, no-shock patients; skip empiric anaerobic coverage when anaerobic risk is low); societies still pushing to retire SEP-1. Covered July 7.
HBV functional cure signal: bepirovirsen 72-week data (~20% cure vs. 0 on placebo). Covered July 8.
Medicare GLP-1 "bridge": $50/mo Wegovy/Zepbound access for eligible Part D beneficiaries, live since July 1. Covered July 9.
Risk-guided antihypertensive eligibility in older adults: Annals piece on targeting treatment by overall CV risk rather than BP threshold. Covered July 10.
Budget launch-monitor roundup (Shot Scope LM1, Blue Tees Rainmaker, Rapsodo MLM2PRO) and the Vampire Lestat / Silo S3 / Beef S2 TV slate — covered earlier this week.